VGF and Alzheimer disease: To validate our prediction of VGF’s role as a KD of AD with protective effects, we pursued three independent validation paths: (1) replication of our results in different brain regions and independent datasets; (2) association of human genetic variation derived risk for AD with VGF expression; and (3) prospective validation of VGF in an experimental model of AD.